GT Biopharma, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
GT Biopharma, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • GT Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 2.23M shares, a 94.5% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 2.23M -38.4M -94.5% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.38M -35.5M -96.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.38M +290K +26.6% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 41.4M +8.91M +27.4% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 40.6M +9.95M +32.4% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 36.9M +4.54M +14% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 1.09M -31M -96.6% Dec 31, 2022 10-K 2024-03-26
Q3 2022 32.5M +2M +6.55% Sep 30, 2022 10-Q 2022-10-31
Q2 2022 30.7M +2.55M +9.06% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 32.3M +11.8M +57.7% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 32.1M +26.8M +514% Dec 31, 2021 10-K 2023-03-30
Q3 2021 30.5M -47M -60.6% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 28.1M -47.3M -62.7% Jun 30, 2021 10-Q/A 2021-12-29
Q1 2021 20.5M -50.1M -70.9% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 5.22M +1.11M +27.1% Dec 31, 2020 10-K 2022-03-28
Q3 2020 77.5M +10.6M +15.9% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 75.4M +22.8M +43.3% Jun 30, 2020 10-Q/A 2020-08-18
Q1 2020 70.6M +19.2M +37.4% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 4.1M -46.5M -91.9% Dec 31, 2019 10-K 2021-04-16
Q3 2019 66.9M +16.7M +33.2% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 52.6M +2.53M +5.04% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 51.4M Mar 31, 2019 10-Q 2019-05-15
Q4 2018 50.7M +533K +1.06% Dec 31, 2018 10-K 2020-03-27
Q3 2018 50.2M +460K +0.92% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 50.1M +49.6M +9995% Jun 30, 2018 10-Q 2018-08-14
Q4 2017 50.1M +50M +47990% Dec 31, 2017 10-K 2019-03-29
Q3 2017 49.8M +21.5M +76.4% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 496K -25.4M -98.1% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 123M +101M +467% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 104K -2.3M -95.7% Dec 31, 2016 10-K 2018-03-01
Q3 2016 28.2M -563M -95.2% Sep 30, 2016 10-Q/A 2018-02-28
Q2 2016 25.9M -566M -95.6% Jun 30, 2016 10-Q/A 2018-02-28
Q1 2016 21.7M -574M -96.4% Mar 31, 2016 10-Q/A 2018-02-28
Q4 2015 2.4M +33.4K +1.41% Dec 31, 2015 10-K/A 2018-02-28
Q3 2015 592M 0 0% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 592M +18.7M +3.26% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 596M +22.7M +3.96% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 2.37M -571M -99.6% Dec 31, 2014 10-K/A 2018-02-28
Q3 2014 592M +18.7M +3.26% Sep 30, 2014 10-Q 2015-01-08
Q2 2014 573M 0 0% Jun 30, 2014 10-Q 2015-01-08
Q1 2014 573M 0 0% Mar 31, 2014 10-Q 2015-01-08
Q4 2013 573M +72.5M +14.5% Dec 31, 2013 10-K 2015-03-31
Q3 2013 573M +116M +25.3% Sep 30, 2013 10-Q 2014-12-17
Q2 2013 573M +209M +57.3% Jun 30, 2013 10-Q 2014-12-12
Q1 2013 573M +273M +90.8% Mar 31, 2013 10-Q 2014-12-10
Q4 2012 501M +231M +85.9% Dec 31, 2012 10-K 2015-01-08
Q3 2012 457M +219M +91.6% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 364M +155M +73.9% Jun 30, 2012 10-Q/A 2012-09-13
Q1 2012 300M Mar 31, 2012 10-Q 2012-05-21
Q4 2011 269M +120M +80% Dec 31, 2011 10-K 2014-11-18
Q3 2011 239M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 209M Jun 30, 2011 10-Q/A 2011-09-12
Q4 2010 150M Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.